Advertisement

CDC Names Top 3 Microbial Threats — Physician’s First Watch

Medical News |
September 17, 2013

CDC Names Top 3 Microbial Threats

By Kelly Young

Carbapenem-resistant Enterobacteriaceae, Clostridium difficile, and drug-resistant Neisseria gonorrhoeae top a list of organisms needing urgent attention, according to a new CDC report that ranks 18 organisms by their level of threat to human health.

At least 2 million people in the U.S. become ill from drug-resistant organisms each year, with at least 23,000 dying, the report states. CDC Director Tom Frieden told reporters: "If we're not careful, we'll soon be in a post-antibiotic era."

Serious (but not urgent) threats include: multidrug-resistant Acinetobacter and Pseudomonas aeruginosa; fluconazole-resistant Candida; extended spectrum β-lactamase producing Enterobacteriaceae; vancomycin-resistant Enterococcus; methicillin-resistant Staphylococcus aureus; and drug-resistant Campylobacter, non-typhoidal Salmonella, Salmonella Typhi, Shigella, and Streptococcus pneumoniae.

The CDC recommends more attention to preventing the spread of resistance, better tracking of resistant infections, and improved antibiotic stewardship.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement